PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Synthesis, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bio-Synthesis, Inc. Launches Peptide Library Generation Software - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries
Bio-Synthesis, Inc. Launches Peptide Library Generation Software

 

NewswireToday - /newswire/ - Lewisville, TX, United States, 2009/09/02 - Bio-Synthesis has launched a new software intended to help with epitope identification and sequence optimization by using six powerful peptide libraries.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Long established custom biomedical manufacturer, Bio-Synthesis, Inc., has launched the Peptide Library Generation Tools Software, a versatile platform complete with six powerful screening tools, each designed to help with epitope identification and sequence optimization to best fit the customer’s current/future applications. The tools include Overlapping Peptide Library, Alanine Scanning Library, Positional Library, Truncation Library, Random Library and Scrambled Library.

Each library has a different ability to assist and evaluate sequences based on the researchers specific needs. The overlapping library breaks down the original protein or peptide into fragments of equal length which allows the researcher to see which segments of the original protein or peptide yield the highest activity. The alanine scanning library is extremely useful in identifying which amino acids are essential to the peptide’s function by indicating the level of importance associated with each replaced amino acid.

The positional library is used when a position or positions in a peptide sequence are each replaced with different amino acids in order to determine the preferred amino acid residues at these positions. The truncation library is extremely useful for determining the minimum length required for optimum peptide activity. The goal of the random library protocol is to substitute randomly selected amino acids with a mixture of all 20 amino acids. The scrambled library is used to examine all possible combinations of the same amino acids from the original sequence.

As technology advances, screening tools such as these libraries prove to be invaluable to research, with each library having its own ability to quickly and efficiently examine and screen a sequence for epitope identification and sequence verification. The sequences generated through the Peptide Library Generation Tools Software can then be passed to Bio-Synthesis, Inc. for custom synthesis, a feature adding to the comprehensive approach to support the growth of more efficient, cost-effective, and focused research.

About Bio-Synthesis, Inc.
Bio-Synthesis, Inc. (biosyn.com), headquartered in Lewisville, Texas, is a leading biomedical manufacturer of custom peptide synthesis, custom antibodies, Custom PNA Synthesis, custom DNA, RNA synthesis, HLA/DNA typing, organic synthesis and a diverse number of bimolecular products for the biomedical/life science community worldwide since 1984. Their staff of highly experienced and qualified chemists, biologists and immunologists has reliably and consistently provided products and services to large pharmaceuticals and universities across the country that meet the most demanding requirements for quality, turnaround and expert technical support.

For more information, please call 1-800-227-0627.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Synthesis, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bio-Synthesis, Inc. Launches Peptide Library Generation Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Angela Ragan - BioSyn.com 
972-420-8505 biosyn[.]biosyn.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Synthesis, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Synthesis, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)